[Chung Chan-seung] The collapse of trust: South Korea's true health care crisis
[KH Explains] Why doctors refuse to bend despite lack of public support
[KH Explains] What does Apple's dead car project mean for Samsung, Hyundai?
Actor Lee Jae-wook vows legal action against malicious rumors
Yoon, Zuckerberg discuss AI, digital ecosystem in Seoul
Police raid striking doctors' homes, offices, after deadline passes on return-to-work order
Interior minister renews calls for trainee doctors to return to work
Bitcoin soars to record high in Korea
Yoon touts improved Japan ties on Independence Movement Day as gateway to 'new world'
S. Korea, US voice 'deep concern' over NK's definition of S. Korea as 'hostile' country
Korea Exchange delays delisting decision for scandal-ridden Kolon TissueGeneBy Yonhap
Published : Dec. 7, 2020 - 21:10
The postponment is expected to provide tech-heavy KOSDAQ-listed Kolon TissueGene a chance to present another turnaround program to the KOSDAQ market committee under the main Korea Exchange (KRX).
The main stock exchange said it will reopen the review meeting, without giving the timeframe.
The postponement came a month after the KRX's earlier assessment that the drugmaker failed to comply with the listing criteria.
Trading of Kolon TissueGene has been suspended since late May last year, as the government revoked its permit to sell Invossa over mislabeling and false reporting of ingredient.
Three months later, the KRX decided to delist the company, unless it submitted plans for improvement.
Last month, the KRX turned down Kolon TissueGene for "insufficient" proposals. The firm repealed the decision, asking for a second reviewing.
Upon the KRX's latest call, Kolon TissueGene now has seven days to submit a new proposal for improvement.
The postponement indicates the KRX's patience for the firm's third-phase clinical test results for Invossa in the United States.
As of its last trading on May 28, Kolon TissueGene's market cap stood at 489.6 billion won, with 34.48 percent stake held by some 65,000 retail investors. (Yonhap)
Yoon touts improved Japan ties on Independence Movement Day
Bill to probe first lady fails to pass
Address by President Yoon Suk Yeol on the 105th March 1st Independence Movement Day